 | • レポートコード：QYR2104Z2687 • 出版社/出版日：QYResearch / 2021年4月10日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、頭頸部扁平上皮がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（外科療法、放射線療法、薬物治療）、用途別市場規模（病院、診療所、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・頭頸部扁平上皮がん治療の市場動向 ・企業の競争状況、市場シェア ・頭頸部扁平上皮がん治療の種類別市場規模（外科療法、放射線療法、薬物治療） ・頭頸部扁平上皮がん治療の用途別市場規模（病院、診療所、外来手術センター） ・頭頸部扁平上皮がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・頭頸部扁平上皮がん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・頭頸部扁平上皮がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・頭頸部扁平上皮がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・頭頸部扁平上皮がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen、AbbVie、Bristol-Myers Squibb、AstraZeneca、Eli Lilly、GlaxoSmithKline、Teva、Roche、Celgene） ・結論 |
Head and neck squamous cell carcinoma is the sixth leading cancer worldwide by incidence. Head and neck squamous cell carcinoma progresses from the mucosal membrane, comprising the paranasal sinuses and nasal cavity, the nasopharynx, the hypopharynx, larynx, and trachea, and the oropharynx and oral cavity. According to WHO, The annual incidence of head and neck squamous cell carcinoma worldwide is more than 550,000 cases with around 300,000 deaths every year. Alcohol and tobacco is the risk factor for head and neck squamous cell carcinoma. Five years survival rate of patients with head and neck squamous cell carcinoma is about 40-50%.
Market Analysis and Insights: Global Head And Neck Squamous Cell Carcinoma Treatment Market
The global Head And Neck Squamous Cell Carcinoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Head And Neck Squamous Cell Carcinoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Head And Neck Squamous Cell Carcinoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Head And Neck Squamous Cell Carcinoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Head And Neck Squamous Cell Carcinoma Treatment market.
Global Head And Neck Squamous Cell Carcinoma Treatment Scope and Market Size
Head And Neck Squamous Cell Carcinoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Head And Neck Squamous Cell Carcinoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Surgical Therapy
Radiation Therapy
Drug Treatment
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Amgen
AbbVie
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
GlaxoSmithKline
Teva
Roche
Celgene
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Head And Neck Squamous Cell Carcinoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgical Therapy
1.2.3 Radiation Therapy
1.2.4 Drug Treatment
1.3 Market by Application
1.3.1 Global Head And Neck Squamous Cell Carcinoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Head And Neck Squamous Cell Carcinoma Treatment Market Perspective (2016-2027)
2.2 Head And Neck Squamous Cell Carcinoma Treatment Growth Trends by Regions
2.2.1 Head And Neck Squamous Cell Carcinoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Head And Neck Squamous Cell Carcinoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Head And Neck Squamous Cell Carcinoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Head And Neck Squamous Cell Carcinoma Treatment Industry Dynamic
2.3.1 Head And Neck Squamous Cell Carcinoma Treatment Market Trends
2.3.2 Head And Neck Squamous Cell Carcinoma Treatment Market Drivers
2.3.3 Head And Neck Squamous Cell Carcinoma Treatment Market Challenges
2.3.4 Head And Neck Squamous Cell Carcinoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Head And Neck Squamous Cell Carcinoma Treatment Players by Revenue
3.1.1 Global Top Head And Neck Squamous Cell Carcinoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Head And Neck Squamous Cell Carcinoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Head And Neck Squamous Cell Carcinoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Head And Neck Squamous Cell Carcinoma Treatment Revenue
3.4 Global Head And Neck Squamous Cell Carcinoma Treatment Market Concentration Ratio
3.4.1 Global Head And Neck Squamous Cell Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Head And Neck Squamous Cell Carcinoma Treatment Revenue in 2020
3.5 Head And Neck Squamous Cell Carcinoma Treatment Key Players Head office and Area Served
3.6 Key Players Head And Neck Squamous Cell Carcinoma Treatment Product Solution and Service
3.7 Date of Enter into Head And Neck Squamous Cell Carcinoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Head And Neck Squamous Cell Carcinoma Treatment Breakdown Data by Type
4.1 Global Head And Neck Squamous Cell Carcinoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Head And Neck Squamous Cell Carcinoma Treatment Forecasted Market Size by Type (2022-2027)
5 Head And Neck Squamous Cell Carcinoma Treatment Breakdown Data by Application
5.1 Global Head And Neck Squamous Cell Carcinoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Head And Neck Squamous Cell Carcinoma Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Head And Neck Squamous Cell Carcinoma Treatment Market Size (2016-2027)
6.2 North America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type
6.2.1 North America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2016-2027)
6.3 North America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application
6.3.1 North America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2016-2027)
6.4 North America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country
6.4.1 North America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size (2016-2027)
7.2 Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type
7.2.1 Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2016-2027)
7.3 Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application
7.3.1 Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2016-2027)
7.4 Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country
7.4.1 Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type
8.2.1 Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application
8.3.1 Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size by Region
8.4.1 Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size (2016-2027)
9.2 Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type
9.2.1 Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application
9.3.1 Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country
9.4.1 Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type
10.2.1 Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application
10.3.1 Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country
10.4.1 Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Head And Neck Squamous Cell Carcinoma Treatment Introduction
11.1.4 Amgen Revenue in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Head And Neck Squamous Cell Carcinoma Treatment Introduction
11.2.4 AbbVie Revenue in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021)
11.2.5 AbbVie Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Head And Neck Squamous Cell Carcinoma Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Head And Neck Squamous Cell Carcinoma Treatment Introduction
11.4.4 AstraZeneca Revenue in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Head And Neck Squamous Cell Carcinoma Treatment Introduction
11.5.4 Eli Lilly Revenue in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021)
11.5.5 Eli Lilly Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Head And Neck Squamous Cell Carcinoma Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Head And Neck Squamous Cell Carcinoma Treatment Introduction
11.7.4 Teva Revenue in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021)
11.7.5 Teva Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Head And Neck Squamous Cell Carcinoma Treatment Introduction
11.8.4 Roche Revenue in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021)
11.8.5 Roche Recent Development
11.9 Celgene
11.9.1 Celgene Company Details
11.9.2 Celgene Business Overview
11.9.3 Celgene Head And Neck Squamous Cell Carcinoma Treatment Introduction
11.9.4 Celgene Revenue in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021)
11.9.5 Celgene Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Head And Neck Squamous Cell Carcinoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgical Therapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Drug Treatment
Table 5. Global Head And Neck Squamous Cell Carcinoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Head And Neck Squamous Cell Carcinoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Head And Neck Squamous Cell Carcinoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Head And Neck Squamous Cell Carcinoma Treatment Market Share by Regions (2016-2021)
Table 9. Global Head And Neck Squamous Cell Carcinoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Head And Neck Squamous Cell Carcinoma Treatment Market Share by Regions (2022-2027)
Table 11. Head And Neck Squamous Cell Carcinoma Treatment Market Trends
Table 12. Head And Neck Squamous Cell Carcinoma Treatment Market Drivers
Table 13. Head And Neck Squamous Cell Carcinoma Treatment Market Challenges
Table 14. Head And Neck Squamous Cell Carcinoma Treatment Market Restraints
Table 15. Global Head And Neck Squamous Cell Carcinoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Head And Neck Squamous Cell Carcinoma Treatment Market Share by Players (2016-2021)
Table 17. Global Top Head And Neck Squamous Cell Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Head And Neck Squamous Cell Carcinoma Treatment as of 2020)
Table 18. Ranking of Global Top Head And Neck Squamous Cell Carcinoma Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Head And Neck Squamous Cell Carcinoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Head And Neck Squamous Cell Carcinoma Treatment Product Solution and Service
Table 22. Date of Enter into Head And Neck Squamous Cell Carcinoma Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Head And Neck Squamous Cell Carcinoma Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Head And Neck Squamous Cell Carcinoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Head And Neck Squamous Cell Carcinoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Head And Neck Squamous Cell Carcinoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Head And Neck Squamous Cell Carcinoma Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Head And Neck Squamous Cell Carcinoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Head And Neck Squamous Cell Carcinoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Amgen Company Details
Table 63. Amgen Business Overview
Table 64. Amgen Head And Neck Squamous Cell Carcinoma Treatment Product
Table 65. Amgen Revenue in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 66. Amgen Recent Development
Table 67. AbbVie Company Details
Table 68. AbbVie Business Overview
Table 69. AbbVie Head And Neck Squamous Cell Carcinoma Treatment Product
Table 70. AbbVie Revenue in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 71. AbbVie Recent Development
Table 72. Bristol-Myers Squibb Company Details
Table 73. Bristol-Myers Squibb Business Overview
Table 74. Bristol-Myers Squibb Head And Neck Squamous Cell Carcinoma Treatment Product
Table 75. Bristol-Myers Squibb Revenue in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 76. Bristol-Myers Squibb Recent Development
Table 77. AstraZeneca Company Details
Table 78. AstraZeneca Business Overview
Table 79. AstraZeneca Head And Neck Squamous Cell Carcinoma Treatment Product
Table 80. AstraZeneca Revenue in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 81. AstraZeneca Recent Development
Table 82. Eli Lilly Company Details
Table 83. Eli Lilly Business Overview
Table 84. Eli Lilly Head And Neck Squamous Cell Carcinoma Treatment Product
Table 85. Eli Lilly Revenue in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 86. Eli Lilly Recent Development
Table 87. GlaxoSmithKline Company Details
Table 88. GlaxoSmithKline Business Overview
Table 89. GlaxoSmithKline Head And Neck Squamous Cell Carcinoma Treatment Product
Table 90. GlaxoSmithKline Revenue in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 91. GlaxoSmithKline Recent Development
Table 92. Teva Company Details
Table 93. Teva Business Overview
Table 94. Teva Head And Neck Squamous Cell Carcinoma Treatment Product
Table 95. Teva Revenue in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 96. Teva Recent Development
Table 97. Roche Company Details
Table 98. Roche Business Overview
Table 99. Roche Revenue in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 100. Roche Recent Development
Table 101. Celgene Company Details
Table 102. Celgene Business Overview
Table 103. Celgene Head And Neck Squamous Cell Carcinoma Treatment Product
Table 104. Celgene Revenue in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 105. Celgene Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Head And Neck Squamous Cell Carcinoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Surgical Therapy Features
Figure 3. Radiation Therapy Features
Figure 4. Drug Treatment Features
Figure 5. Global Head And Neck Squamous Cell Carcinoma Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Head And Neck Squamous Cell Carcinoma Treatment Report Years Considered
Figure 10. Global Head And Neck Squamous Cell Carcinoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Head And Neck Squamous Cell Carcinoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Head And Neck Squamous Cell Carcinoma Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Head And Neck Squamous Cell Carcinoma Treatment Market Share by Regions (2022-2027)
Figure 14. Global Head And Neck Squamous Cell Carcinoma Treatment Market Share by Players in 2020
Figure 15. Global Top Head And Neck Squamous Cell Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Head And Neck Squamous Cell Carcinoma Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Head And Neck Squamous Cell Carcinoma Treatment Revenue in 2020
Figure 17. Global Head And Neck Squamous Cell Carcinoma Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Head And Neck Squamous Cell Carcinoma Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Head And Neck Squamous Cell Carcinoma Treatment Market Share by Type (2016-2027)
Figure 21. North America Head And Neck Squamous Cell Carcinoma Treatment Market Share by Application (2016-2027)
Figure 22. North America Head And Neck Squamous Cell Carcinoma Treatment Market Share by Country (2016-2027)
Figure 23. United States Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Head And Neck Squamous Cell Carcinoma Treatment Market Share by Type (2016-2027)
Figure 27. Europe Head And Neck Squamous Cell Carcinoma Treatment Market Share by Application (2016-2027)
Figure 28. Europe Head And Neck Squamous Cell Carcinoma Treatment Market Share by Country (2016-2027)
Figure 29. Germany Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Share by Region (2016-2027)
Figure 39. China Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Head And Neck Squamous Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Amgen Revenue Growth Rate in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021)
Figure 59. AbbVie Revenue Growth Rate in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021)
Figure 62. Eli Lilly Revenue Growth Rate in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021)
Figure 64. Teva Revenue Growth Rate in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021)
Figure 66. Celgene Revenue Growth Rate in Head And Neck Squamous Cell Carcinoma Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed